RDNT
RadNet, Inc. (NASDAQ)
Healthcare — Diagnostics & Research
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
Price History
Fundamentals
| Market Cap | $5.16B |
| P/E Ratio (TTM) | - |
| Forward P/E | 69.56 |
| EPS (TTM) | $-0.17 |
| Dividend Yield | - |
| Profit Margin | -0.66% |
| Revenue Growth | 22.10% |
| ROE | 1.77% |
| Debt/Equity | 143.00 |
| Recommendation | Strong Buy 1.3 |
| Analyst Target | $89.75 |
| Analysts | 8 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 67.1 |
| Beta | 1.39 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $85.84 |
| 52-Week Low | $50.76 |
| 50-Day Avg | $56.26 |
| 200-Day Avg | $67.83 |
| Avg Volume | 877.7K |
| Volume | $1.01M |
Performance Analysis
BULLISHRDNT shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:28 UTC
Back to Screener Export Report